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Host responseOmsk hemorrhagic fever virus (OHFV) and Russian spring–summer encephalitis virus (RSSEV) are tick-borne
ﬂaviviruses that have close homology but different pathology and disease outcomes. Previously, we reported
that C57BL/6 andBALB/cmicewere excellentmodels to study the pathology and clinical signs of humanRSSEV
and OHFV infection. In the study described here, we found that RSSEV infection induced robust release of
proinﬂammatory cytokines (IL-1α, IL-1β, IL-6 and TNF-α) and chemokines (MCP-1, MIP-1β, RANTES and KC)
in the brain at 9 and 11dpi, together with moderate to low Th1 and Th2 cytokines. In contrast, OHFV infection
stimulated an early and prominent induction of IL-1α, TNF-α, IL-12p70, MCP-1, MIP-1α and MIP-1β in the
spleen of infected mice. Collectively our data suggest that a differential host response to infection may lead to
the alternate disease outcomes seen following OHFV or RSSEV infection.Facility, 8200 Research Plaza,
9 5029.
lbrook).
ll rights reserved.© 2010 Elsevier Inc. All rights reserved.Introduction
Omsk hemorrhagic fever virus (OHFV) and Russian spring-
summer encephalitis virus (RSSEV) are tick-borne ﬂaviviruses of the
genus Flavivirus, family Flaviviridae. These viruses are NIAID Category
C priority pathogens and potential biothreat agents. Although these
two virus groups are antigenically closely related with ~90%
homology in their amino acid sequences, they cause vastly different
disease outcomes in humans. OHFV can cause haemorrhagic fever
syndromes in humans, but clinical expression ranges widely between
mild to moderate clinical courses (Lvov et al., 1988). RSSEV is a
member of the tick-borne encephalitis (TBEV) serocomplex, and it
causes potentially fatal neurological infection. It is endemic across
Asia including northern, western and southwestern regions of China
(Lu et al., 2008), northern Japan (Takashima et al., 1997) and Russia.
Cytokines play a crucial role in the regulation of the immune response
in clearing virus and protecting the host. However, overproduction of
cytokines and chemokines may play a deleterious role. The innate and
adaptive immune responses,with special reference to the cytokineproﬁle,
during OHFV or RSSEV infection are largely unknown. However, it has
been reported that various proinﬂammatorymediators such as TNF-α, IL-
1α and IL-6 were elevated in human TBE patients (Atrasheuskaya et al.,2003;Kondrusik et al., 2001;Timofeevet al., 2002;Toporkovaet al., 2008).
The decline of these proinﬂammatory cytokines together with an
elevation of IL-10 was also associated with recovery (Atrasheuskaya et
al., 2003; Kondrusik et al., 2001). However, the role of cytokines in OHFV
and RSSEV infection in humans or animal models was never indicated.
Very few studies have been conducted to determine the role of the
cellular immune response during OHFV or RSSEV infection. In TBE
patients, T-cell subsets were signiﬁcantly elevated in CSF as compared
to the peripheral blood (Gelpi et al., 2005; Tomazic and Ihan, 1997).
Similarly, the number of lymphocytes in the peripheral blood did not
show a signiﬁcant increase as a result of OHFV or RSSEV infection of
BALB/c or C57BL/6 mice (Tigabu et al., 2009). Adoptive transfer of
CD4+ T-cells improves the survival of SCID mice after TBEV infection
(Ruzek et al., 2009). Although the mechanism behind this is not yet
clear, CD4+ T-cells play a protective role in TBEV infection in mice.
However, mice lacking CD8+ T-cells showed extended survival and
decreased mortality, indicating a major contribution of the host
immune system to the development of TBE (Ruzek et al., 2009).
Understanding the role of the host immune response in disease
pathogenesis is important for the development of immune protection
with minimal negative effects. BALB/c and C57BL/6 mice have been
used as a reliable model to study disease progress following OHFV or
RSSEV/TBEV infection (Hayasaka et al., 2009; Holbrook et al., 2005;
Ruzek et al., 2009; Tigabu et al., 2009). Previously, we have shown that
infected BALB/c and C57BL/6 mice have clinical signs and pathology
similar to those seen in humans. RSSEV-infected mice have severe
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to complete ﬂaccid paralysis. However, OHFV infected mice have
viscerotropic disease with limited signs of neurological disease
(Holbrook et al., 2005; Tigabu et al., 2009).
In the current study, we investigated the extent to which cellular
reactivity and cytokine production during experimental RSSEV and
OHFV infection may contribute to the difference in pathology and
disease outcome of these two viruses. We identiﬁed a robust and
predominant proinﬂammatory response, along with a modest Th1
response during RSSEV infection in the brain. In contrast, OHFV
primarily caused an early inﬂammatory response in the visceral
organs with minimal effect on the brain.
Results
RSSEV infection induced the release of proinﬂammatory cytokines in the
brain
We recently showed that OHFV caused viscerotropic disease, while
RSSEV caused encephalitis in the BALB/c and C57BL/6 mouse modelsFig. 1. Kinetics of inﬂammatorymediators and Th1/Th2 cytokines in the brain of BALB/cmice fo
cytokines, (B) Chemokines, (C) Th1 cytokines and (D) Th2 cytokinesweremeasured in the brai
are shown as mean±SD for 3-5 mice at each time point. *pb0.05 for the comparison between(Holbrook et al., 2005; Tigabu et al., 2009). In the present study, we
investigated the role of cytokines following RSSEV or OHFV infection
by determining the proﬁle and levels of proinﬂammatory cytokines
using a Bioplex assay. The brain was analyzed for cytokines (IL-1α, IL-
1β, IL-2, IL-4, IL-5, IL-6, IL-9, IL-10 IL-12, IL-13, and IL-17) and
chemokines (KC, G-CSF, GM-CSF, MCP-1α, MIP-1α, MIP-1β and
RANTES). A general trend towards an increase in the expression of
proinﬂammatory cytokines was observed in the brain of RSSEV
infected BALB/c mice as compared to mock or OHFV infection (Fig. 1).
The concentrations of proinﬂammatory cytokines and chemokines
were elevated in RSSEV infection at the later time of infection. The
expression of IL-1α was enhanced 5-fold and 8-fold (pb0.05) in
RSSEV infected mice on 9 and 11 days post infection (dpi),
respectively, when compared with OHFV infected mice. Similarly,
the level of IL-1β was elevated 2-fold at day 9 and 3-fold at 11 days
post RSSEV infection, respectively, when compared to OHF infection.
The increase in TNF-α was as great as 11-fold and 9-fold (pb0.05) on
9 and 11 dpi, respectively, when compared with the OHFV infection.
In the case of IL-6, none of the mock and only very few OHFV-infected
mice released detectable level of IL-6 in the brain. In contrast, RSSEVllowing ( )mock, ( ) OHFVor (■) RSSEV infection. Protein levels of (A) proinﬂammatory
n at the indicated time points following foot pad injection of 1000pfu OHFV or RSSEV. Data
RSSEV and mock, pb0.05 for comparison between RSSEV and OHFV.
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(Fig. 1A). Amongst the proinﬂammatory molecules investigated,
increases in the expression of MCP-1, MIP-1β and RANTES were the
highest (Fig. 1B). These chemokines elevated dramatically in RSSEV
infection starting from 7 dpi, and this enhanced level was maintained
and reached a peak at 11 dpi. Unlike the OHFV infected mice, the
enhancement of these chemokines in the brains of RSSEV infected
mice was statistically signiﬁcant (pb0.05) when compared with the
mock controls. Contrary to the elevated proinﬂammatory cytokines,
RSSEV infection induced a very small amount of the Th2 and
regulatory cytokines IL-4, IL-5 and IL-10 (Fig. 1D). Taken together,
there was an overall induction of proinﬂammatory cytokines and
chemokines in the brain following RSSEV infection, but a limited
response in OHFV infected animals.
The levels of Th1 cytokines were increased moderately in the
BALB/cmouse as a result of RSSEV infection (Fig. 1C). IL-2 increased to
4 and 6-fold (pb0.05) by day 9 and 11, respectively when compared
to mock. IL-12p40 showed an increase of 270- and 463-fold (pb0.05)
on 9 and 11 dpi, respectively. In addition, IL-12p70 increased 14-foldFig. 2. Inﬂammatory mediators in the spleen following ( ) mock, ( ) OHFV or (■) RSSEV in
and the level of the cytokine was measured from the clear homogenates. Data are the mean±
and mock, pb0.05 for comparison between RSSEV and OHFV.at day 9, but it decreased over time andwas not statistically signiﬁcant
when compared to that of OHFV ormock infectedmice. IFN-γwas also
elevated at day 9 and 11; however, it was not signiﬁcantly different
from OHFV infected mice.
In C57BL/6mice, similar trends of cytokine and chemokine release
were observed (data not shown) where RSSEV infected mice
predominantly released proinﬂammatory cytokines, which were
higher compared to OHFV infection. However, the magnitude of
elevation of IL-6, KC, IFN-γ and IL-4 in RSSEV infected C57BL/6 mice
were smaller as compared to RSSEV infected BALB/c mice.
OHFV induced high concentration of proinﬂammatory mediators in the
spleen
Previous studies showed that OHFV causes enlargement of the
spleen with evidence of necrosis (Atrasheuskaya et al., 2003; Holbrook
et al., 2005; Tigabu et al., 2009). We also found that the OHFV/RSSEV
titer in the spleen ranges between 2 and 3 log10 pfu/ml. In the present
study, we detected signiﬁcantly higher levels of proinﬂammatoryfection of (A) BALB/c and (B) C57BL/6 mice. Spleen was extracted at the indicated time
SD for 3–5 mice at each time point. *pb0.05 for the comparison between OHFV/RSSEV
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with the mock or RSSEV infected mice. The concentration of
inﬂammatory mediators peaked at 3 dpi in OHFV infected BALB/c
mice (Fig. 2A). TNF-α and IL-1α were elevated 2-fold at 3 dpi as
compared to the RSSEV infected BALB/c. In addition, IL-12p70 was
signiﬁcantly (pb0.01) elevated in OHFV infected BALB/c mice as
compared to RSSEV infected. Similarly, MCP-1, MIP-1α and MIP- 1β
were signiﬁcantly higher (pb0.001) at 3 dpi in OHFV infected BALB/c
mice when compared with RSSEV infected mice. This elevation of
proinﬂammatory cytokines and chemokineswas at 3 dpi, and decreased
over time. One exception was RANTES where the highest signiﬁcant
increase over RSSEV infectionwas on days 7 and 9 (pb0.01). In the case
of RSSEV infection, cytokines remained low throughout the infection
period. However, the chemokineswere elevated at 11 dpi. IL-4, IL-5 and
IL-6were not detected in the spleen of uninfected or infectedmice. In all
cases, a higher cytokine release in the spleen corresponded to higher
virus titer. There was no correlation between the virus titer in the brain
and the cytokine concentration in the spleen (data not shown).
OHFV or RSSEV infected C57BL/6 mice had a similar pattern of
cytokine release as that of OHFV infected BALB/c mice. However, the
overall cytokine and chemokine release in the spleen of C57BL/6 mice
was lower than that of BALB/c mice (Fig. 2B).
OHFV infection also induced chemokines in the lung and liver
Only a few mouse groups had positive OHFV titer in the lung, thus
no correlation was established between the virus titer and the
cytokine release. At 3 dpi, MCP-1 (pb0.05), RANTES (pb0.05) and KC
were elevated in OHFV infected BALB/c mice as compared to that of
mock, however, the elevation of RANTESwas extended to day 7. In the
case of MCP-1 and KC, the level went down and then increased again
at 9–11 dpi (Fig. 3). In RSSEV infected BALB/c mice, the level of MCP-1
and KC were increased at 9–11 dpi.
OHFV infected mice had 2–2.8 log10 pfu/ml OHFV titer in the liver
at 7 and 9 dpi, however, no RSSEV was detected in liver of infected
mice using plaque assay (Tigabu et al., 2009). In terms of the hepatic
cytokine level, there are few differences between infected and control
BALB/c and C57BL/6 mice (data not shown).
Cytokine levels in the brain and spleen were higher than those in serum
Previously, we reported that no virus was detected in the serum of
either OHFV or RSSEV infected mice (Tigabu et al., 2009), thus a direct
correlation between virus titer and cytokine release could not be
established. In the current study, we found that the level of cytokines in
the serum of OHFV or RSSEV infected mice increased above the level of
themock at 9 and 11 dpi; however, therewas only slight variation in the
cytokine levels between virus infected mice (data not shown). InFig. 3. Chemokine expression in lung of BALB/c mice following ( ) mock, ( ) OHFV or (■) R
the supernatant was used to analyze the level of cytokines/chemokines. Data are shown as m
RSSEV and mock, pb0.05 for comparison between RSSEV and OHFV.addition, there was no signiﬁcant correlation between either OHFV or
RSSEV titer in the brain and the concentration of their corresponding
cytokines in the serum (data not shown). All tested cytokines were
higher in thebrain of RSSEV infectedmice comparedwith thoseof serum
(Table 1). Similarly, the cytokines in the spleen of OHFV infected mice
were higher as compared to the serum (data not shown). This higher
cytokine concentration in the brain of RSSEV infected mice and visceral
organs of OHFV infected mice as compared to their corresponding
cytokines in the serum suggest localized inﬂammatory responses.
OHFV and RSSEV had limited effect on the proportion of splenic CD4+
and CD8+ cells
We have previously reported that OHFV infection leads to necrosis
in the spleen (Holbrook et al., 2005). Thus, to better understand the
effect of OHFV and RSSEV on the cell population of the spleen, we
analyzed the proportion of total T cells, B-lymphocytes, CD4+ T cells,
CD8+ T cells, granulocytes, NK, myeloid DC and plasmacytoid DC. The
total number of splenocytes was not affected following RSSEV
infection in either BALB/c or C57BL/6 mice. Fig. 4 shows the results
of ﬂow cytometry analysis indicating the proportion of CD3+T-cells,
CD4+ and CD8+T-cells, B-cells, plasmocytoid dendritic cells
(pDCs), granulocytes and NK cells in the spleen. The proportion of
splenic CD4+T-cells was not signiﬁcantly affected by OHFV or RSSEV
infection in either BALB/c or C57BL/6 mice. However, both OHFV and
RSSEV infections signiﬁcantly (pb0.01) increased the proportion of
CD8+T-cells, as compared to mock, during the early phase of infection
in BALB/c mice. This increase was enhanced signiﬁcantly (pb0.05) in
the OHFV infected BALB/c mice on 7–11 dpi as compared to RSSEV.
In OHFV infectedmice, the proportion of NK, granulocytes and pDC
was higher at 3 dpi as compared to RSSEV. However, RSSEV infection
increased the proportion of these cells at the later time of the infection
period. The proportion of mDC did not vary appreciably between
infected and control groups (data not shown).
Discussion
In this study, we examined the host immune response to OHFV and
RSSEV infection in the mouse model with the objective of character-
izing the response and correlating the response to disease progression
and pathogenesis. As we have shown before (Holbrook et al., 2005;
Tigabu et al., 2009), OHFV and RSSEV caused markedly different
diseases in the animal model with viscerotropic disease associated
with OHFV infection and neurologic disease characterizing RSSEV
infection. Here we show that the host immune response can be linked
to differential disease manifestations.
The ﬁrst important feature we found was that RSSEV infection,
which causes encephalitis in humans andmice, results in an excessiveSSEV infection of BALB/ c mice. Lung and liver were extracted at the indicated days and
ean±SD for 3–5 mice at each time point. *pb0.05 for the comparison between OHFV/
Table 1
Comparison of the fold change of cytokine/chemokine levels in the brain and serum of
RSSEV infected BALB/c mice over the mock.
9 dpi 11 dpi
Brain Serum Brain Serum
IL-1α 23.5±12.2 2.1 ±1.9 9.5±4 116.0 ±133
IL-1β 3.9±1.3 0.8 ±0.3 5.4±1.7 5.1±4.4
TNF-α 16.7±9.8 0.3±0.2 14.3±8.5 2.7±1.9
IL-10 5.2±2.6 0.4 ±0.3 15.4±7.7 6.5±6.6
IL-12p40 271.6±15.5 1.1±0.5 463.9±207 4.7±3.8
IL-2 3.8±1.5 0.4±0.2 6.1±2.4 3.9±3.4
IFN-γ 28.7±20.9 0.5±0.4 186.5±93.5 1.4±1.5
KC 20.0±10 1.4±0.9 46.8±26.5 3.5±2.4
MCP-1 1315.1±1260 0.9±0.6 666.4±600 9.6±9.9
MIP-1β 661.7±431 0.2±0.1 1389±11.8 4.4±3.9
RANTES 261.9±150 0.5±0.3 555±293 2.5±1.8
G-CSF 211.6±122 3.7±2.9 65.3±33 121±140
Data are shown as mean±SE for 3–5 mice at each time point.
The cytokine level in the brain of RSSEV infected mice were signiﬁcantly higher
(pb0.05) when compared to that of the serum.
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concentration of the proinﬂammatory cytokines (IL-1α, IL-1β, IL-6
and TNF-α), and chemokines (MCP-1, MIP-1α, MIP-1β, KC and
RANTES) positively correlated with the increase of the RSSEV titer in
the brain. This release of proinﬂammatory cytokines was signiﬁcantlyFig. 4. The effect of OHFV and RSSEV infection on the proportion of the splenocyte subsets of B
Dissociated splenocytes were isolated on the designated days post infection. The cells were s
as mean±SD for 5 mice at each time point. *pb0.05 for the comparison between OHFV/RShigher when compared to OHFV. Similarly, TBE patients had the
highest level of TNF-α, IL-1α and IL-6 during the ﬁrst week of
hospitalization, and treatment reducing these cytokines led to
quicker improvement of symptoms and consequently faster recovery
(Atrasheuskaya et al., 2003). IL-6 could be neurotoxic, has been
associated with neurological disorders and disease (Okuda et al.,
1998; Olson et al., 2001; Perrin et al., 2000) and induces other
proinﬂammatory cytokines such as IL-1β and TNF-α. IL-1α and TNF-α
act synergistically to initiate the cascade of inﬂammatory mediators
by targeting the endothelium. Thus, increasedbrain productionof IL-6,
TNF-α and IL-1α/βmay explain the observed inﬂammatory response,
neuronal damage, meningitis, meningioencephalitis and meningioen-
cephalomyelitis evident during RSSEV infection (Gunther et al., 1997;
Toporkova et al., 2008).
RSSEV infection also caused a dramatic increase in the level of
brain MCP-1, MIP-1β and RANTES compared to OHFV infection.
Similar results were reported in human TBE patients where MCP-1 in
CSF was signiﬁcantly increased in comparison to the control group
(Michalowska-Wender et al., 2006). Moreover, RANTES increased in
the CSF, but not in serum of TBE patients (Grygorczuk et al., 2006;
Lepej et al., 2007) suggesting its role in the recruitment of cells into
CSF. Furthermore, chemokines alter the permeability of the BBB as
well as stimulating macrophages and microglia in the brain leading to
cellular migration and secretion of proinﬂammatory mediators
(Ghoshal et al., 2007; Ishiguro et al., 1997).ALB/c (A) and C57BL/6 (B) mice were infected with ( ) mock, ( ) OHFV or (■) RSSEV.
tained with appropriate antibodies and analyzed using ﬂow cytometry. Data are shown
SEV and mock, pb0.05 for comparison between RSSEV and OHFV.
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(IL-2, IFN-γ, IL-12p40 and IL-12p70) in thebrain of RSSEV infectedmice.
In addition, the level of IL-4, IL-5 and IL-10 was either very low or
undetectable inmost RSSEV infectedmice. Earlier studies indicated that
TBE recovery was associated with decreased levels of proinﬂammatory
cytokines accompanied by an elevation of IL-10 (Atrasheuskaya et al.,
2003). Other studies also indicated that IL-2 was associated with
recovery from TBE and had a strong negative correlation with IL-1β,
TNF-α and IL-6 (Atrasheuskaya et al., 2003; Lepej et al., 2007). This
diminished or absence of negative regulations in the brain of RSSEV
infected mice may create perpetuation of a primarily proinﬂammatory
environment in the brain that could result in death of the host through
immunopathogenesis.
Contrary to RSSEV, OHFV infection caused a sharp decrease in the
body weight of infected mice with pathology mainly in visceral
organs. The main pathology of OHFV in human infections includes
hemorrhages in the GI, urinary and reproductive tracts, and
hyperplasia of spleen. In mice, OHFV was detected as early as 3 dpi
in visceral organs and had higher virus titer compared to RSSEV
(Holbrook et al., 2005; Tigabu et al., 2009). Our results indicated an
early increase of proinﬂammatory mediators including IL-1α and
TNF-α, together with chemokines (MCP-1, MIP-1α, MIP-1β and
RANTES) in the spleens of OHFV infected mice. These cytokines and
chemokines were elevated signiﬁcantly at 3 dpi as compared to RSSEV
ormock; and have a positive correlationwith virus titer. The release of
cytokines and chemokines in the spleen earlier than they are seen in
the serum and brain suggests the ampliﬁcation of the immune
response to OHFV was generated peripherally. The high level of
proinﬂammatory mediators with the absence of regulatory cytokines
may induce tissue injury which can lead to organ dysfunction. A very
limited amount of data regarding OHFV infection of humans and/or
mice makes it difﬁcult to correlate the cytokine level with disease
stage or outcome. However, in several viral hemorrhagic fevers,
overproduction of proinﬂammatory cytokines such as IL-1β andTNF-α
contributes to vascular endothelial cell dysfunction and, consequently,
shock (Geisbert and Jahrling, 2004; Marta et al., 1999).
Infection with other hemorrhagic fever viruses (e.g. Ebola) lead to
depletion of peripheral and/or splenic NK, CD4+ and CD8+ T cells.
The death of these cells was suggested to contribute to the disease
progression (Reed et al., 2004 and Zaki and Goldsmith, 1999).
Previously we have shown that OHFV infected mice had their
peripheral lymphocytes number dropped at 3 dpi and subsequently
returned to the level of the control. However, in the current study,
depletion of splenic subsets was absent. This may indicate that there
might not be a strong correlation between the number of the
splenocytes subsets and the pathology of OHFV infection. However,
the activation state of the cells and their effect on the production and
modulation of the cytokine and chemokine levels needs further study.
Serum cytokine levels of OHFV or RSSEV infected mice started to
increase above mock late in the disease cycle. In addition, the level of
cytokines in the serum was lower when compared to that of the brain
and visceral organs. Activated macrophages in the spleen and brain
macrophages/monocytes, astrocytes, microglial and endothelial cells in
the CNS are known to release cytokines/chemokines when stimulated
byviral infection (Chenet al., 2000, 2004; del Zoppo et al., 2000;Ghoshal
et al., 2007) thereby releasing them to the circulation and contributing
to the elevated cytokine level in serum. This further potentiates the
exaggerated endogenous production of proinﬂammatory cytokines by
brain and visceral organswhichmay be responsible for tissue injury and
ultimately organ failure. Similarly, TBE patients demonstrated elevated
IL-6, IL-10, and IFN-γ in the CSF relative to serum concentrations
(Pietruczuk et al., 2006; Zajkowska et al., 2006) indicating that a serum
cytokine proﬁle is unreliable in determining the inﬂammation status in
the brain.
In this report, we describe mouse strain-based differences in levels
of cytokines and chemokines induced by infection with OHFV andRSSEV. Within each group of BALB/c or C57BL/6 mice the general
trend of the cytokine response is similar where RSSEV infected mice
have excess proinﬂammatory cytokines in the brain and OHFV
infected mice have high cytokine response in the visceral organs.
However, when the cytokine response was compared between the
two groups of mice, the BALB/c mice exhibited a higher overall
response. This could be due to other confounding factors, such as the
genetic background of the mice and involvement of other aspects of
the immune system (e.g. cell mediated immunity) in determining the
survival time of infected mice. Differences in immune responses of
BALB/c and C57BL/6 mice have been reported following infection
with viruses (Culley et al., 2006; Weinberg et al., 2004). In general,
C57BL/6 mice tend to mount a Th1 response, while BALB/c mice tend
to mount a Th2 response (Spellberg and Edwards, 2001). In our
previous work, we indicated that BALB/c mice have higher average
survival time following RSSEV infection but shorter following OHFV
infection when compared to infected C57BL/6 mice. In addition, the
viral titer in CNS did not show signiﬁcant difference between OHFV
and RSSEV infected BALB/c and C57BL/6 mice (Tigabu et al., 2009).
Based on this and previous studies, we hypothesize that, although
both OHFV and RSSEV replicate in the brain, they may have different
cell tropism. RSSEV may lead to activation of inﬂammatory cells,
including microglia, which results in release of exaggerated proin-
ﬂammatory mediators that might play a major role in the mortality of
infected mice due mainly to encephalitis. Excess proinﬂammatory
mediators in the visceral organs due to OHFV infection may also be
responsible for the visceral organ pathology. Deregulated or excess
release of proinﬂammatory mediators by brain or visceral organs may
induce tissue damage with different pathology and disease outcome.
This suggests a major role of cytokines and chemokines in the
immunopathogenesis of RSSEV and OHFV infection. The host immune
response may therefore play a central role in determining the clinical
outcome of OHFV/RSSEV infection. Further studies are needed to
determine the target cells for each virus and address the speciﬁc




Female C57BL/6 and BALB/cmice aged 8–10 weekswere purchased
from Harlan Sprague–Dawley, and were kept in the ABSL-4 animal
facilities of the UTMB, Galveston, TX. All procedures were performed in
our ABSL-4 facility according to Institutional Animal Care and Use
Committee guidelines, and were in accordance with the Principles of
Laboratory Animal Care.
Virus and challenge procedure
RSSEV (strain Sofjin) and OHFV (strain Guriev) were obtained
from the World Reference Collection for Emerging Viruses and
Arboviruses (WRCEVA), which is housed at UTMB, Galveston, TX.
Animals were challenged with 1000 pfu (20 μl) in the left-rear
footpad. Mock infected animals were inoculated with 20 μl of diluent
(serum-free MEM).
Isolation of tissue
Five mice from each virus andmock infected group were sacriﬁced
every other day for 15 days. Blood was drained by cardiac puncture
and sera were separated by centrifugation. Half of each brain, spleen,
liver, and lung were collected and homogenized in 0.5 ml of PBS. The
serum and tissue homogenates were immediately stored at −80 °C
until analyzed by cytokine Bioplex assay and virus titration. The viable
63B. Tigabu et al. / Virology 408 (2010) 57–63virus titer in these tissue homogenates was determined using plaque
assay and reported previously (Tigabu et al., 2009).
Cytokine analysis
Serum and clariﬁed homogenate supernatant were used to
determine the cytokine proﬁle of the infected mice. Cytokine analysis
was done in triplicate using a mouse-speciﬁc 23-plex Bioplex assay
(Bio-Rad) according to the manufacturer's instruction.
Preparation of spleen cell suspensions
Single cell suspensions were prepared from the spleens by forcing the
spleen through 40-μm pore size screen. Splenocytes were suspended in
cold complete RPMI 1640 and centrifuged topellet the cells. The red blood
cells were lysed using lysis buffer (eBiosciences). The cell suspensionwas
washed twice with cold RMPI 1640 and the splenocyte count was
performed using a hemocytometer. Cell viability was determined using
the trypan blue (Gibco) exclusion method and was greater than 95%.
Flow cytometry
Flow cytometric analysis was performed on a FACSCanto (Becton
Dickinson, San Jose, CA). All antibodies used in this experiment were
purchased from eBiosciences. The splenocytes suspensions were
incubated at 4 °C for 30 minutes with antibodies. The splenocytes
were then washed twice and ﬁxed in 4% paraformaldehyde for 24 h.
Cellswere identiﬁedasT-cells (CD3+), CD4+Tcells (CD3+CD4+), CD8+
T cells (CD3+CD8+), B lymphocytes (B220+, CD3-), mDC (CD11c+
CD11b+B220-), pDC(CD11cloCD11b- B220+) andNK (CD3-DX5+B220-)
usingﬂow cytometry. Splenocyteswere analyzed using FACSCanto, and
FCS Express was used for data analysis.
Statistical analyses
Data are expressed as mean±SD of 3–5 mice per group. Statistical
analysis of the cytokines and chemokines was performed using two-
way ANOVA followed by Tukey post Hoc or Kruskal–Wallis test.
Relationships between variables were evaluated pair-wise by Pearson's
correlation. All data analyses were done using SigmaPlot®11 software
and values of pb0.05 was considered to be statistically signiﬁcant.
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